Page 100 - Read Online
P. 100

Page 14 of 18                                                 Kozarov et al. Vessel Plus 2020;4:10  I  http://dx.doi.org/10.20517/2574-1209.2019.31

               27.  Elkind MSV, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, et al. Infectious burden and risk of stroke: the Northern
                   Manhattan Study. Arch Neurol 2010;67:33-8.
               28.  Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, et al. Infectious burden and cognitive function: the Northern Manhattan Study.
                   Neurology 2013;80:1209-15.
               29.  Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, et al.; Oral Infections and Vascular Disease Epidemiology
                   Study (INVEST). Relationship between periodontal disease, tooth loss, and carotid artery plaque: the Oral Infections and Vascular
                   Disease Epidemiology Study (INVEST). Stroke 2003;34:2120-5.
               30.  Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, et al. Periodontal microbiota and carotid intima-media
                   thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 2005;111:576-82.
               31.  Engebretson SP, Lamster IB, Elkind MS, Rundek T, Serman NJ, et al. Radiographic measures of chronic periodontitis and carotid
                   artery plaque. Stroke 2005;36:561-6.
               32.  Desvarieux M, Demmer RT, Jacobs DR Jr, Rundek T, Boden-Albala B, et al. Periodontal bacteria and hypertension: the oral infections
                   and vascular disease epidemiology study (INVEST). J Hypertens 2010;28:1413-21.
               33.  Boillot A, Demmer RT, Mallat Z, Sacco RL, Jacobs DR, et al. Periodontal microbiota and phospholipases: the Oral Infections and
                   Vascular Disease Epidemiology Study (INVEST). Atherosclerosis 2015;242:418-23.
               34.  Elter JR, Champagne CM, Offenbacher S, Beck JD. Relationship of periodontal disease and tooth loss to prevalence of coronary heart
                   disease. J Periodontol 2004;75:782-90.
               35.  Rydén L, Buhlin K, Ekstrand E, de Faire U, Gustafsson A, et al. Periodontitis increases the risk of a first myocardial infarction: a
                   report from the PAROKRANK Study. Circulation 2016;133:576-83.
               36.  Górski B, Nargiełło E, Grabowska E, Opolski G, Górska R. The association between dental status and risk of acute myocardial
                   infarction among poles: case-control study. Adv Clin Exp Med 2016;25:861-70.
               37.  Nordendahl E, Gustafsson A, Norhammar A, Näsman P, Rydén L, et al.; PAROKRANK Steering Committee. Severe periodontitis is
                   associated with myocardial infarction in females. J Dent Res 2018;97:1114-21.
               38.  Pasqualini D, Bergandi L, Palumbo L, Borraccino A, Dambra V, et al. Association among oral health, apical periodontitis, CD14
                   polymorphisms, and coronary heart disease in middle-aged adults. J Endod 2012;38:1570-7.
               39.  Morita T, Yamazaki Y, Fujiharu C, Ishii T, Seto M, et al. Association between the duration of periodontitis and increased
                   cardiometabolic risk factors: a 9-year cohort study. Metab Syndr Relat Disord 2016;14:475-82.
               40.  Jönsson D, Orho-Melander M, Demmer RT, Engström G, Melander O, et al. Periodontal disease is associated with carotid plaque area:
                   the Malmö Offspring Dental Study (MODS). J Intern Med 2020;287:301-9.
               41.  Cotti E, Dessì C, Piras A, Mercuro G. Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the
                   literature. Int J Cardiol 2011;148:4-10.
               42.  Cotti E, Mercuro G. Apical periodontitis and cardiovascular diseases: previous findings and ongoing research. Int Endod J
                   2015;48:926-32.
               43.  Chauhan N, Mittal S, Tewari S, Sen J, Laller K. Association of apical periodontitis with cardiovascular disease via noninvasive
                   assessment of endothelial function and subclinical atherosclerosis. J Endod 2019;45:681-90.
               44.  Pussinen PJ, Mattila K. Periodontal infections and atherosclerosis: mere associations? Curr Opin Lipidol 2004;15:583-8.
               45.  Amar S, Wu SC, Madan M. Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications.
                   J Immunol 2009;182:1584-92.
               46.  Epstein SE, Zhu J, Najafi AH, Burnett MS. Insights into the role of infection in atherogenesis and in plaque rupture. Circulation
                   2009;119:3133-41.
               47.  Genco R, Offenbacher S, Beck J. Periodontal disease and cardiovascular disease: epidemiology and possible mechanisms. J Am Dent
                   Assoc 2002;133:14S-22.
               48.  Beck JD, Eke P, Heiss G, Madianos P, Couper D, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure.
                   Circulation 2005;112:19-24.
               49.  Beck JD, Moss KL, Morelli T, Offenbacher S. Periodontal profile class is associated with prevalent diabetes, coronary heart disease,
                   stroke, and systemic markers of C-reactive protein and interleukin-6. J Periodontol 2018;89:157-65.
               50.  Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, et al. Antibodies to periodontal pathogens are associated with coronary
                   heart disease. Arterioscler Thromb Vasc Biol 2003;23:1250-4.
               51.  Pussinen PJ, Alfthan G, Rissanen H, Reunanen A, Asikainen S, et al. Antibodies to periodontal pathogens and stroke risk. Stroke
                   2004;35:2020-3.
               52.  Pussinen PJ, Alfthan G, Jousilahti P, Paju S, Tuomilehto J. Systemic exposure to Porphyromonas gingivalis predicts incident stroke.
                   Atherosclerosis 2007;193:222-8.
               53.  Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, et al. Periodontitis decreases the antiatherogenic potency of
                   high density lipoprotein. J Lipid Res 2004;45:139-47.
               54.  Kim HJ, Cha GS, Kim HJ, Kwon EY, Lee JY, et al. Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-
                   density lipoprotein. J Periodontal Implant Sci 2018;48:60-8.
               55.  Pussinen PJ, Könönen E, Paju S, Hyvärinen K, Gursoy UK, et al. Periodontal pathogen carriage, rather than periodontitis, determines
                   the serum antibody levels. J Clin Periodontol 2011;38:405-11.
               56.  Miyashita H, Honda T, Maekawa T, Takahashi N, Aoki Y, et al. Relationship between serum antibody titres to Porphyromonas
                   gingivalis and hs-CRP levels as inflammatory markers of periodontitis. Arch Oral Biol 2012;57:820-9.
   95   96   97   98   99   100   101   102   103   104   105